CS154294B2 - - Google Patents

Info

Publication number
CS154294B2
CS154294B2 CS155670A CS155670A CS154294B2 CS 154294 B2 CS154294 B2 CS 154294B2 CS 155670 A CS155670 A CS 155670A CS 155670 A CS155670 A CS 155670A CS 154294 B2 CS154294 B2 CS 154294B2
Authority
CS
Czechoslovakia
Application number
CS155670A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS154294B2 publication Critical patent/CS154294B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CS155670A 1969-03-10 1970-03-09 CS154294B2 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH358369A CH500196A (de) 1969-03-10 1969-03-10 Verfahren zur Herstellung von neuen Azepinderivaten

Publications (1)

Publication Number Publication Date
CS154294B2 true CS154294B2 (en:Method) 1974-03-29

Family

ID=4259115

Family Applications (1)

Application Number Title Priority Date Filing Date
CS155670A CS154294B2 (en:Method) 1969-03-10 1970-03-09

Country Status (24)

Country Link
US (2) US3642775A (en:Method)
AT (1) AT298492B (en:Method)
BE (1) BE747085A (en:Method)
BG (1) BG17576A3 (en:Method)
BR (1) BR7017332D0 (en:Method)
CA (1) CA920586A (en:Method)
CH (1) CH500196A (en:Method)
CS (1) CS154294B2 (en:Method)
DE (1) DE2011087C3 (en:Method)
DK (1) DK125649B (en:Method)
ES (1) ES377279A1 (en:Method)
FI (1) FI50523C (en:Method)
FR (1) FR2034781B1 (en:Method)
GB (1) GB1310571A (en:Method)
HK (1) HK51976A (en:Method)
IE (1) IE34046B1 (en:Method)
IL (1) IL34026A (en:Method)
KE (1) KE2635A (en:Method)
MY (1) MY7600194A (en:Method)
NL (1) NL162904C (en:Method)
NO (1) NO130314B (en:Method)
PL (1) PL80549B1 (en:Method)
SE (1) SE349301B (en:Method)
YU (1) YU33862B (en:Method)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
EP0108715A1 (de) * 1982-10-15 1984-05-16 Ciba-Geigy Ag Dibenzazepincarboxamide
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
PT101876B (pt) * 1996-05-27 1999-09-30 Portela & Ca Sa Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
US20020022056A1 (en) * 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
ATE224347T1 (de) 1998-11-25 2002-10-15 Dsm Fine Chem Austria Gmbh Verfahren zur oxidation von methyl-, methylen- oder methingruppen enthaltenden substraten
AT406957B (de) * 1998-11-25 2000-11-27 Dsm Fine Chem Austria Gmbh Verfahren zur oxidation von methyl-, methylen- oder methingruppen enthaltenden substraten
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
IT1317854B1 (it) * 2000-02-25 2003-07-15 Farchemia Srl 5-ciano-10-idrossi-10,11-diidro-5h-dibenz(b,f)azepina e procedimentiper la sua preparazione e per la sua conversione in
US7183272B2 (en) * 2001-02-12 2007-02-27 Teva Pharmaceutical Industries Ltd. Crystal forms of oxcarbazepine and processes for their preparation
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients
MXPA06002392A (es) 2003-09-03 2006-06-20 Novartis Ag Uso de oxcarbazepina para el tratamiento de dolor neuropatico diabetico y la mejora del sueno.
EP1678140A2 (en) * 2003-10-20 2006-07-12 Amoli Organics Ltd. Novel process for preparation of 10-oxo-10, 11-dihydro-5h-dibenz [b,f]azepine-5-carboxamide (oxcarbazepine) via intermediate, 10-methoxy-5h-dibenz [b,f] azepine-5-carbonylchloride
ITMI20040452A1 (it) * 2004-03-09 2004-06-09 Clariant Lsm Italia Spa Processo per la preparazione di oxcarbazepina
US7459553B2 (en) * 2004-03-11 2008-12-02 Glenmark Generics Ltd. Process for the preparation of carboxamide compounds
WO2005096709A2 (en) * 2004-03-11 2005-10-20 Sun Pharmaceutical Industries Limited A process for the preparation of 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
EP1600443A1 (en) * 2004-05-26 2005-11-30 Alberto Milanese Process for the preparation of oxcarbazepine
CA2471666C (en) * 2004-06-18 2009-10-13 Apotex Pharmachem Inc. An improved process for the preparation of oxcarbazepine and related intermediates
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
JP5253381B2 (ja) 2006-04-26 2013-07-31 スパーナス ファーマシューティカルズ インコーポレイテッド シグモイド放出プロファイルを有するオキサカルバゼピンの制御放出製剤
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US20090082335A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched oxcarbazepine
WO2009073154A1 (en) 2007-11-28 2009-06-11 Nektar Therapeutics Al, Corporation Oligomer-tricyclic conjugates
US8530647B2 (en) * 2008-05-08 2013-09-10 Mylan Laboratories Limited Process for the preparation of oxcarbazepine
WO2011091050A1 (en) 2010-01-19 2011-07-28 Nektar Therapeutics Oligomer-tricyclic conjugates
EP2900640A1 (en) 2012-09-26 2015-08-05 Ranbaxy Laboratories Limited Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
EP3397253A1 (en) 2015-12-30 2018-11-07 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of seizure-related disorders
PL3554490T3 (pl) 2016-12-16 2022-05-30 Idorsia Pharmaceuticals Ltd Kombinacja farmaceutyczna zawierająca bloker kanału wapniowego typu T
US10639313B2 (en) 2017-09-01 2020-05-05 Ndsu Research Foundation Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
US20210338685A1 (en) 2018-09-28 2021-11-04 Griffith University Agents and methods for modulating pathogen activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH403767A (de) * 1961-06-09 1965-12-15 Geigy Ag J R Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen

Also Published As

Publication number Publication date
DE2011087A1 (de) 1970-09-24
YU33862B (en) 1978-06-30
ES377279A1 (es) 1972-12-16
MY7600194A (en) 1976-12-31
KE2635A (en) 1976-06-11
IL34026A0 (en) 1970-05-21
NO130314B (en:Method) 1974-08-12
IE34046B1 (en) 1975-01-08
NL7003022A (en:Method) 1970-09-14
BG17576A3 (bg) 1973-11-10
IL34026A (en) 1972-12-29
PL80549B1 (en:Method) 1975-08-30
US3642775A (en) 1972-02-15
AT298492B (de) 1972-05-10
BE747085A (fr) 1970-09-09
DK125649B (da) 1973-03-19
DE2011087C3 (de) 1979-08-30
NL162904C (nl) 1980-07-15
FR2034781B1 (en:Method) 1973-04-06
DE2011087B2 (de) 1978-12-21
FI50523C (fi) 1976-04-12
YU53670A (en) 1977-12-31
FI50523B (en:Method) 1975-12-31
HK51976A (en) 1976-08-27
GB1310571A (en) 1973-03-21
NL162904B (nl) 1980-02-15
IE34046L (en) 1970-09-10
CH500196A (de) 1970-12-15
BR7017332D0 (pt) 1973-01-04
US3716640A (en) 1973-02-13
CA920586A (en) 1973-02-06
FR2034781A1 (en:Method) 1970-12-18
SE349301B (en:Method) 1972-09-25

Similar Documents

Publication Publication Date Title
FI50523B (en:Method)
AU429630B2 (en:Method)
CS153762B1 (en:Method)
CS152356B2 (en:Method)
CS152378B2 (en:Method)
AU442375B2 (en:Method)
AU427401B2 (en:Method)
AU425297B2 (en:Method)
AU428131B2 (en:Method)
AU410358B2 (en:Method)
AU442357B2 (en:Method)
AU428129B2 (en:Method)
AU438128B2 (en:Method)
AU414607B2 (en:Method)
AU417208B2 (en:Method)
AU428074B2 (en:Method)
CS152064B1 (en:Method)
AU4923469A (en:Method)
CS150360B1 (en:Method)
AU5079269A (en:Method)
CS148488B1 (en:Method)
AU5133369A (en:Method)
AU5228269A (en:Method)
CH662270A4 (en:Method)
AU4982068A (en:Method)